Ping An Good Doctor
China's biggest online health platform, bundling telehealth with parent Ping An's insurance base.
On the record
Checkpoint: FY2026 annual report discloses new related-party revenue share and any parent buy-in move
The call
A profitable health platform whose growth leans harder each year on its own parent, while bigger AI-armed rivals circle the same market.
Ping An Good Doctor runs a healthcare and insurance app in China with real revenue and millions of users, but most of its customers come from its parent company, Ping An Insurance, rather than being its own strength. The company faces serious competition from much larger rivals like JD Health and Alibaba, who are building similar AI-powered health services and already have bigger customer bases and distribution networks to reach people. The key question is whether Ping An Good Doctor can grow its own independent customer base or if it will remain dependent on being fed customers by its parent company, which is a risky position if the parent company's strategy changes.
Why
01
AI pressure: JD Health, Alibaba Health, Meituan, DiDi AI health agents. Rivals ship comparable AI doctor tools at far bigger scale (JD Health is 13x its size), pressuring pricing and user share. Could AI do the core job? Unlikely.
02
Bigger players: Ping An Insurance Group (its own controlling parent). Parent-linked revenue jumped from 34% to 41.7% of total in one year, meaning growth is increasingly borrowed, not won. Could a giant copy it? Probably.
03
What protects it. Deep integration into Ping An's 250M+ insurance customers gives it distribution rivals must build from scratch.
What would change this call
Ping An Good Doctor's related-party revenue share in the FY2026 annual report (due March 2027). Rising above 45 percent would show deepening reliance on parent Ping An Insurance, not independent wins.
Any privatization or buy-in announcement from Ping An Insurance Group regarding Ping An Good Doctor. Would signal the parent is absorbing the unit rather than letting it compete independently.
Corporate health (B-end) revenue growth rate in H1 2026 results (due Aug-Sept 2026). Sustained above 30% YoY would show the business winning clients on its own, not just via parent distribution.
Any privatization or buy-in announcement from Ping An Insurance Group regarding Ping An Good Doctor. Would signal the parent is absorbing the unit rather than letting it compete independently.
Corporate health (B-end) revenue growth rate in H1 2026 results (due Aug-Sept 2026). Sustained above 30% YoY would show the business winning clients on its own, not just via parent distribution.
Key numbers
- Revenue RMB5.47B, up 13.7% YoY
- Parent-linked revenue share hit 41.7%, up from 34%
- AI Family Doctor reached 90M monthly users
Named risks
- Rising related-party revenue share (34% to 41.7% in FY2025) signals dependence, not independent share.
- Revenue scale gap versus JD Health (roughly 13x) compresses growth ceiling as rivals escalate AI spend.
- Conflicting headcount data and zero job postings in 2025 suggest possible hiring freeze despite reported profit.
- Repeated financial-reporting and segment reclassifications flagged by Morningstar as a governance risk.
- Extreme stock volatility, trading far below its HK$148.50 all-time high as of July 2026.
Rivals, as read in July 2026
| Rival | Direction | Evidence |
|---|---|---|
| JD Health | gaining on | RMB73.4B FY2025 revenue vs PAGD's RMB5.47B, roughly 13x larger, as of Dec 31, 2025 |
| Alibaba Health | contesting | Anzhen'er AI agent connects 2,000+ institutions, serves 200M+ people as of June 8, 2026 |
| Meituan | contesting | Expanding into corporate/senior-care health digitization as of mid-2026 |
| DiDi | contesting | Expanding into medical-escort accompanying-consultation services in 2026 |
| WeDoctor (Tencent-backed) | gaining on | Targeting ~US$7B IPO valuation as of June 30, 2026 |
Questions people ask
- Is Ping An Good Doctor profitable in 2026?
- Yes. For FY2025 (ended Dec 31, 2025), Ping An Good Doctor reported revenue of RMB5.47 billion (+13.7% YoY) and profit attributable to owners of RMB379.5 million, up 366.1% YoY, marking its second consecutive annual profit, per its March 24, 2026 results release.
- Who owns Ping An Good Doctor?
- Ping An Insurance (Group) Company of China is the controlling shareholder, holding between 38.4% and 54.6% depending on the source (Morningstar vs Simply Wall St), as of June 2026. It is HKEX-listed as 1833.HK, not a private company.
- Could AI replace Ping An Good Doctor's doctors?
- Partially for triage. Its AI Family Doctor served ~90 million monthly active users by July 2026 and cut per-consultation cost ~45% YoY in Q4 2025, but Chinese medical regulation still requires licensed human sign-off on diagnosis and prescriptions, so full replacement is currently blocked by law.
- Who is Ping An Good Doctor's biggest competitor?
- JD Health, which reported FY2025 revenue of RMB73.4 billion (+23% YoY) versus Ping An Good Doctor's RMB5.47 billion, roughly 13 times larger, with 218 million active users as of December 31, 2025.
- How dependent is Ping An Good Doctor on its parent company?
- Heavily and growing. Revenue from Ping An Group and affiliates rose to about 41.7% of total revenue in FY2025 (ended Dec 31, 2025), up from roughly 34% a year earlier, indicating the business increasingly relies on its parent's insurance distribution rather than independent market wins.
- Is Ping An Good Doctor stock volatile?
- Very. As of July 22, 2026, the stock's 52-week range was HK$6.57 to HK$24.40, far below its all-time high of HK$148.50 and just above its all-time low of HK$5.53, reflecting a steep post-IPO decline followed by a partial 2026 rebound.
Timeline
- 2026-07-21Ping An Group reportedly pauses US private market investments amid unspecified concerns
- 2026-07-21AI Family Doctor showcased at WAIC 2026, reaches ~90 million monthly active users
- 2026-07-16Ping An Circle offline partner-store network surpasses 10,000 stores in 136 cities
- 2026-05-31Ping An Home service launches, covering 120 cities and ~300,000 eligible customers
- 2026-03-26Jefferies upgrades stock from Underperform to Hold, raises target HK$5.9 to HK$12.4
- 2026-03-24FY2025 annual results: revenue RMB5.47B, profit RMB379.5M, second straight profitable year
- 2025-06-11Company reverts consumer brand back to Ping An Good Doctor
- 2021-01-27Consumer app renamed from Ping An Good Doctor to Ping An Health
- 2018-05-04Company lists on HKEX Main Board as 1833.HK
Revision history
22 July 2026
First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.
In the same band
Sources
- Ping An Good Doctor Reports 2025 Annual Results (2026-03-24)
- Ping An Good Doctor Posts Second Consecutive Annual Profit (2026-03-26)
- Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand (2025-06-11)
- Major policy initiatives are reshaping industrial benchmarks, bringing Ping An Good Doctor to a critical junct (2026-07-16)
- Ping An Unveils Innovative AI Solutions in Healthcare Insurance and Payments at WAIC 2026 (2026-07-21)
- Ping An Circle surpasses 10,000 stores nationwide (2026-07-16)
- Ping An Good Doctor Reports 2025 Annual Results (2026-07-21)
- gurufocus.com (2026-07-22)
- 01833 Stock Price Quote (2026-06-29)
- Ping An Healthcare and Technology Company (HKG) (2025-12-30)
- PingAn Medical and Healthcare Number of Employees 2026 (2026-06-29)
- Ping An Good Doctor APP Officially Gets Renamed Ping An Health (2021-01-27)